Maine Medicine Weekly Update - 02/26/2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
•  BREAKING: Washington Post Reports, “FDA advisers recommend authorization of Johnson & Johnson single-dose coronavirus vaccine”
•  BREAKING: Maine Adopts Age-based Approach to Expanding Vaccine Eligibility
•  Committee Delays Debate on Bill to Eliminate Nurse Practitioner Training
•  “Community Based Collaboration Form” Vaccine Request Available from Maine DHHS/CDC
•  Maine PMP to Stay with Appriss System
•  CMS Special Enrollment Period for Marketplace Coverage 2021
•  Sue Woods, MD, MPH-- Internet connectivity that just works will help Maine thrive
•  Incoming MMA President, Jeffrey Barkin, MD, DFAPA on WGAN Radio
•  Next MMA Legislative Call Will Be Wednesday, March 3rd
•  Daniel Hanley Center for Health Leadership’s Renowned Physician Executive Leadership Institute – The Advanced Course Enrollment is OPEN
•  PPE Available Through the MMA & ActionPPE
•  A Message from Maine Responds: Volunteer Opportunity
MAINE LEGISLATURE
•  Maine Legislature Week 7 Update
•  Maine Legislature: Public Hearings & Work Sessions
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions
•  Suicide Prevention and Management in Healthcare Practice Settings: A Comprehensive Evidence-Based Approach
•  Maine CDC Annual Prevention Professionals Conference - March 2nd-3rd
•  AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Nursing Director
•  Medical Director - Bucksport Regional Health Center
•  Rangeley Family Medicine seeks Physician
•  Nurse Practitioner
•  Physician
•  Psychiatric Nurse Practitioner

 

BREAKING: Washington Post Reports, “FDA advisers recommend authorization of Johnson & Johnson single-dose coronavirus vaccine”

According to Post reports, “An expert committee unanimously recommended Friday that the Food and Drug Administration authorize a coronavirus vaccine from Johnson & Johnson, making it all but certain there will soon be a third vaccine in the United States, the first to require just a single shot.”

 

According to Post reports, “An expert committee unanimously recommended Friday that the Food and Drug Administration authorize a coronavirus vaccine from Johnson & Johnson, making it all but certain there will soon be a third vaccine in the United States, the first to require just a single shot.” 

The Food and Drug Administration is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorized for emergency use in the U.S. It's the next step in a process that could end with the new vaccine's rollout early next week.